ADS-ADEA 2016* Clinical Science
Chairs: Elif Ekinci & Jennifer Conn
The contribution of glycaemic status to the progression of kidney disease among Indigenous Australians with and without albuminuria– the eGFR follow-up study (#30)
11:00 AM
Soluble urokinase plasminogen activator receptor (suPAR) levels and decline in estimated glomerular filtration rate (eGFR) in patients with diabetes (#31)
11:15 AM
Trajectories of eGFR decline over a four year period: the eGFR Follow-up Study (#32)
11:30 AM
Effect of Empagliflozin on Nephropathy in Subgroups by Age: Results from EMPA-REG OUTCOME (#33)
11:45 AM
Tumour Necrosis Factor-alpha Receptor 1 and 2 are Reduced in patients with Type 1 Diabetes and Hyperfiltration (#34)
12:00 PM
Determinants of offloading devices to reduce plantar pressure in the diabetic foot (#35)
12:15 PM
Annual incidence and risk factors for developing infection in people with diabetes-related foot ulcers (#36)
12:30 PM
Assessment of Microcirculation in the Foot of People with Diabetes with Laser Speckle Contrast Imaging (#37)
12:45 PM